Navigation Links
EnvoyHealth, CMT Piloting Adherence Technology Program

FLINT, Mich., July 28, 2017 /PRNewswire/ --EnvoyHealth, a Diplomat company, has partnered with Compliance Meds Technologies (CMT) to pilot a program for CleverCap LITE, a technology designed to improve patient medication adherence.

CMT strives to deliver innovative health technology solutions and services that help track and improve patients' medication adherence.

CleverCap LITE offers medication monitoring and control for patients and providers. The compact, high-tech bottle cover:

  • Records date and time of bottle access
  • Records if a medication bottle isn't properly reclosed
  • Works with bottles or liquid vials
  • Features visual and audio reminders, as well as a silent option

"One of the largest problems in health care is nonadherence to prescription medication," said Jenny Cretu, senior vice president of pharma services and marketing. "Piloting technologies like CleverCap is key to long-term patient engagement and can help us understand crucial data and improve patient care and outcomes."

According to the American Heart Association, medication nonadherence takes the lives of 125,000 Americans annually and costs the U.S. health care system nearly $300 billion per year in doctor visits, emergency department visits, and hospitalizations.

Not adhering to a medication regimen with respect to timing, dosage, and/or duration can interfere with a patient's ability to treat and manage a disease, leading to a greater risk for complications and a lower quality of life.

"We are very excited about the partnership with Diplomat and EnvoyHealth," said Moses Zonana, founder and CEO of CMT. "Our platform and engagement technology provides an ideal foundation for integrated medication management programs; our combined strengths set a new standard for outpatient medication management. With CMT, patients can be engaged when necessary, providing intelligent touchpoints and a better allocation of resources."

To learn more about EnvoyHealth, visit

Forward-Looking Statements
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give current expectations or forecasts of future events or our future financial or operating performance. The forward-looking statements contained in this press release are based on management's good-faith belief and reasonable judgment based on current information. These statements are qualified by important risks and uncertainties, many of which are beyond our control, that could cause our actual results to differ materially from those forecasted or indicated by such forward-looking statements. For a discussion of such risks and uncertainties, you should review Diplomat's filings with the Securities and Exchange Commission, including "Risk Factors" in Diplomat's Annual Report on Form 10-K for the year ended Dec. 31, 2016, and in subsequent reports filed with or furnished to the Securities and Exchange Commission. Except as may be required by any applicable laws, Diplomat assumes no obligation to publicly update such forward-looking statements, which are made as of the date hereof or the earlier date specified herein, whether as a result of new information, future developments or otherwise.

About Diplomat
Diplomat (NYSE: DPLO) is the nation's largest independent provider of specialty pharmacy services—helping patients and providers in all 50 states. The company offers medication management programs for people with complex chronic diseases and delivers unique solutions for manufacturers, hospitals, payors, providers, and more. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: "Take good care of patients and the rest falls into place." Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information, visit

About Compliance Meds Technologies (CMT)
CMT is a healthcare technology solutions provider with award-winning solutions designed to improve outcomes and mitigate financial risk by allowing providers to accurately track and manage medication utilization, and communicate in real-time with patients and caregivers. CMT solutions are intuitive, easy-to-use, cost-effective, and developed based upon the strategic needs and objectives of each client company. For more information, visit

Kali Lucas, Public Relations Specialist
810.768.9580 |

Jenny Cretu, Senior Vice President,
Pharma Services and Marketing
810.768.9370 |

View original content with multimedia:

SOURCE EnvoyHealth, a Diplomat company
Copyright©2017 PR Newswire.
All rights reserved

Related medicine technology :

1. El Camino Hospital and Leaf Healthcare Piloting a Pressure Ulcer Prevention Program Using Innovative Patient Monitoring Technology
2. Inovalon Partners with Pharmacy Quality Alliance to Evaluate Medication Adherence Quality Performance Measure
3. New Medication Management And Adherence App, MyMeds, Introduced For iPhone, Android, Web; Unites Consumers, Pharmacists, Caregivers, Physicians
4. Patient Adherence, Communication and Engagement (PACE)
5. mHealth Identified as Critical Strategy in Medication Adherence Programs
6. CVS Caremark Research Finds New, More Accurate Method for Classifying Patient Medication Adherence Behaviors
7. New Research: Home Delivery Boosts Adherence
8. Pharma Should Factor Medication Adherence Into Drug Development
9. Personal Health Record Associated with Improved Medication Adherence
10. Novartis Pharmaceuticals Corporation stands behind medication adherence activities and reaffirms commitment to patient safety
11. CVS Caremark Research Finds Optimal Adherence to Medications Prescribed Post-Heart Attack Reduces Hospital Readmissions
Post Your Comments:
(Date:10/5/2017)... 5, 2017  In response to the nationwide ... Maxillofacial Surgeons (AAOMS) released prescribing recommendations that urge ... used as a first-line therapy to manage a ... Recognizing the value and importance ... "Opioid Prescribing: Acute and Postoperative Pain Management" stresses ...
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and ... financial results for the third quarter of 2017 on ... conference call on that day with the investment community ... The conference call will begin at 9 ... can access a live webcast of the conference call ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... , ... October 13, 2017 , ... Lori R. Somekh, ... member of ElderCounsel, a national organization of elder law and special needs planning attorneys. ... and rules. It also provides a forum to network with elder law attorneys nationwide,” ...
(Date:10/13/2017)... ... , ... The Visiting Nurse Association (VNA) of Somerset Hills is proud to ... unique items from across the nation, this holiday-themed event will raise funds and awareness ... VNA. The boutique will be open Saturday, November 4 (10:00 a.m. – 5:00 ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to ... to save lost souls in the Philippines. “The Journey: From the Mountains to the ... teacher of the Bible. She has taught all ages and currently teaches a class ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
Breaking Medicine News(10 mins):